The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1245-1252

  Gonzalgo, Mark L ^a   Hayashida, Toshiro ^a   Bender, Christina M ^a   Pao, Martha M ^a   Tsai, Yvonne C ^a   Gonzales, Felicidad A ^a   Nguyen, Hung D ^a   Nguyen, TuDung T ^a   Jones, Peter A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTEIN P16; PROTEIN P19; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BLADDER CANCER; CONTROLLED STUDY; DNA METHYLATION; GENE ISOLATION; GENE LOCATION; GENE LOCUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

AZACITIDINE; CARRIER PROTEINS; CELL CYCLE PROTEINS; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P19; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032521402     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Li, E., Bestor, T., and Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69: 915-926, 1992.
2. Feinberg, A. P. Genomic imprinting and gene activation in cancer. Nat Genet., 4: 110-113, 1993.
3. Rainier, S., and Feinberg, A. P. Genomic imprinting, DNA methylation, and cancer. J. Natl. Cancer Inst., 86: 753-759, 1994.
4. Ferguson-Smith, A. C., Sasaki, H., Cattanach, B. M., and Surani, M. A. Parental origin-specific epigenetic modification of the mouse H19 gene. Nature (Lond.), 362: 751-755, 1993.
5. Li, E., Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
6. Pfeifer, G. P., Steigerwald, S. D., Hansen, R. S., Gartler, S. M., and Riggs, A. D. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc. Natl. Acad. Sci. USA, 87: 8252-8256, 1990.
7. Hansen, R. S., Ellis, N. A., and Gartler, S. M. Demethylation of specific sites in the 5′ region of the inactive X-linked human phosphoglycerate kinase gene correlates with the appearance of nuclease sensitivity and gene expression. Mol. Cell. Biol., 8: 4692-4699, 1988.
8. Ohtani Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., and Sakai, T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8: 1063-1067, 1993.
9. Zhang, Y., Shields, T., Crenshaw, T., Hao, Y., Moulton, T., and Tycko, B. Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet 53: 113-124, 1993.
10. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., and Dryja, T. P. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am. J. Hum. Genet., 48: 880-888, 1991.
11. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
12. Jones, P. A. DNA methylation errors and cancer. Cancer Res., 56: 2463-2467, 1996.
13. Gonzalgo, M. L., and Jones, P. A. Mutagenic and epigenetic effects of DNA methylation. Mutat. Res., 386: 107-118, 1997.
14. Baylin, S. B., Makos, M., Wu, J. J., Yen, R. W., de Bustros, A., Vertino, P., and Nelkin, B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells, 3: 383-390, 1991.
15. Larsen, F., Gundersen, G., Lopez, R., and Prydz, H. CpG islands as gene markers in the human genome. Genomics, 13: 1095-1107, 1992.
16. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
17. Bestor, T. H., and Tycko, B. Creation of genomic methylation patterns. Nat. Genet., 12: 363-367, 1996.
18. Yoder, J. A., Walsh, C. P., and Bestor, T. H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet., 13: 335-340, 1997.
19. Bird, A. P. The essentials of DNA methylation. Cell, 70: 5-8, 1992.
20. Gardiner-Garden, M., and Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196: 261-282, 1987.
21. Smit, A. F. The origin of interspersed repeats in the human genome. Curr. Opin. Genet. Dev., 6: 743-748, 1996.
22. Schmid, C. W. Alu: structure, origin, evolution, significance and function of one-tenth of human DNA. Prog. Nucleic Acid Res. Mol. Biol., 53: 283-319, 1996.
23. Steenman, M. J., Rainier, S., Dobry, C. J., Grundy, P., Horon, I. L., and Feinberg, A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet., 7: 433-439, 1994.
24. Sasaki, M., Jones, P. A., Chaillet, J. R., Ferguson-Smith, A. C., Barton, S. C., Reik, W., and Surani, M. A. Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev., 6: 1843-1856, 1992.
25. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
26. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
27. Kamb, A., Gruis, N. A., Weaver Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
28. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
29. Pollock, P. M., Pearson, J. V., and Hayward, N. K. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer, 15: 77-88, 1996.
30. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular palhogenesis. Cancer Res., 54: 4855-4878, 1994.
31. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J. P., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55: 4525-4530, 1995.
32. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
33. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T., Beart, R. W., Van Tornout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
34. Lo, K. W., Cheung, S. T., Leung, S. F., van Hasselt, A., Tsang, Y. S., Mak, K. F., Chung, Y. F., Woo, J. K., Lee, J. C., and Huang, D. P. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res., 56: 2721-2725, 1996.
35. Costello, J. F., Berger, M. S., Huang, H. S., and Cavenee, W. K. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res., 56: 2405-2410, 1996.
36. Maesawa, C., Tamura, G., Nishizuka, S., Ogasawara, S., Ishida, K., Terashima, M., Sakata, K., Sato, N., Saito, K., and Satodate, R. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Cancer Res., 56: 3875-3878, 1996.
37. Mao, L., Merlo, A., Bedi, G., Shapiro, G. I., Edwards, C. D., Rollins, B. J., and Sidransky, D. A novel p16/INK4a transcript. Cancer Res., 55: 2995-2997, 1995.
38. Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H., Parry, D., Peters, G., and Kamb, A. Complex structure and regulation of the p16 (MTS1) locus. Cancer Res., 55: 2988-2994, 1995.
39. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83: 993-1000, 1995.
40. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
41. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA, 89: 1827-1831, 1992.
42. Jones, P. A. Altering gene expression with 5-azacytidine. Cell, 40: 485-486, 1985.
43. Bender, C. M., Pao, M. M., and Jones, P. A. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res., 58: 95-101, 1998.
44. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
45. Jones, P. A. Gene activation by 5-azacytidine. In: A. Razin, H. Cedar, and A. D. Riggs (eds.), DNA Methylation: Biochemistry and Biological Significance, pp. 165-187. New York: Springer-Verlag, 1984.
46. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
47. Gonzalgo, M. L., and Jones, P. A. Rapid quantitation of methylation differences at specific sites using melhylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res., 25: 2529-2531, 1997.
48. Gonzalgo, M. L., Bender, C. M., You, E. H., Glendening, J. M., Flores, J. F., Walker, G. J., Hayward, N. K., Jones, P. A., and Fountain, J. W. Low frequency of p16/ CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res., 57: 5336-5347, 1997.
49. Robertson, K. D., Hayward, S. D., Ling, P. D., Samid, D., and Ambinder, R. F. Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-aza-cytidine treatment: evidence that demethylation at a single CpG site is crucial. Mol. Cell. Biol., 15: 6150-6159, 1995.
50. Bryans, M., Kass, S., Seivwright, C., and Adams, R. L. Vector methylation inhibits transcription from the SV40 early promoter. FEBS Lett., 309: 97-102, 1992.
51. Graessmann, M., Graessmann, A., Wagner, H., Werner, E., and Simon, D. Complete DNA methylation does not prevent polyoma and simian virus 40 virus early gene expression. Proc. Natl. Acad. Sci. USA, 80: 6470-6474, 1983.
52. Magewu, A. N., and Jones, P. A. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hotspot in human cancer. Mol. Cell. Biol., 14: 4225-4232, 1994.
53. Yang, A. S., Gonzalgo, M. L., Zingg, J. M., Millar, R. P., Buckley, J. D., and Jones, P. A. The rate of CpG mutation in Alu repetitive elements within the p53 tumor suppressor gene in the primate germline. J. Mol. Biol., 258: 240-250, 1996.
54. Hasse, A., and Schulz, W. A. Enhancement of reporter gene de novo methylation by DNA fragments from the α-fetoprotein control region. J. Biol. Chem., 269: 1821-1826, 1994.
55. Larsen, F., Solheim, J., and Prydz, H. A methylated CpG island 3′ in the apolipoprotein-E gene does not repress its transcription. Hum. Mol. Genet., 2: 775-780, 1993.
56. Stoger, R., Kubicka, P., Liu, C. G., Kafri, T., Razin, A., Cedar, H., and Barlow, D. P. Maternal-specific methylation of the imprinted mouse Igf2r locus identifies the expressed locus as carrying the imprinting signal. Cell, 73: 61-71, 1993.
57. Keshet, I., Yisraeli, J., and Cedar, H. Effect of regional DNA methylation on gene expression. Proc. Natl. Acad. Sci. USA, 82: 2560-2564, 1985.